<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02240472</url>
  </required_header>
  <id_info>
    <org_study_id>SENOMAC</org_study_id>
    <nct_id>NCT02240472</nct_id>
  </id_info>
  <brief_title>Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.</brief_title>
  <official_title>Survival and Axillary Recurrence Following Sentinel Node-positive Breast Cancer Without Completion Axillary Lymph Node Dissection - a Randomized Study of Patients With Macrometastases in the Sentinel Node</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Swedish Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swedish Cancer Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since the introduction of sentinel node biopsy in breast cancer, it has become clear that its
      use is reliable and reproducible. Today, it is clinical routine to not remove further lymph
      nodes from the axilla (arm pit) in case the sentinel node (which is the first lymph node/s
      reached by lymphatic flow from the breast) is free of tumor deposits. It is also routine to
      leave remaining lymph nodes behind in case the sentinel node contains a minimal cluster of
      tumor cells, called isolated tumor cells (formerly submicrometastasis). Even in slightly
      larger tumor deposits, so called micrometastasis (up to 2 mm in size), it has been shown that
      a completion axillary clearance (removal of further lymph nodes from the arm pit) does not
      contribute to a better survival. Data from a randomized study indicate that it seems safe to
      omit axillary clearance even if the sentinel node biopsy shows up to 2 nodes with tumor
      deposits over 2 mm in size (macrometastasis). These studies have changed clinical practice in
      many countries, however, it is still debated whether it is safe to omit axillary clearance in
      the case of sentinel node macrometastasis due to under-recruitment in the aforementioned
      study. The rationale for omitting extensive axillary surgery is the avoidance of
      postoperative morbidity such as arm lymphedema, loss of sensation, pain and swelling.

      The hypothesis is that refraining from axillary clearance in breast cancer patients with 1-2
      sentinel nodes with macrometastasis will not worsen breast cancer-specific survival by more
      than a maximum of 2.5% after 5 years.

      This study is a prospective international randomized trial including 3500 patients.

      Breast cancer patients without signs of axillary nodal involvement will be eligible for
      sentinel node biopsy. Those who are found to have up to two sentinel node containing
      macrometastasis will be informed about this trial Those wishing to participate will be
      randomized to either undergo further axillary surgery (clearance) or not. Outcome measures
      are breast cancer-specific survival, disease-free survival, axillary recurrence rate and
      overall survival.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Details can be found on www.senomac.se
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2029</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>breast cancer-specific survival</measure>
    <time_frame>up to 15 years</time_frame>
    <description>death due to breast cancer in both arms measured at a median follow-up of 5, 10 and 15 years</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>disease-free survival</measure>
    <time_frame>5, 10 and 15 years</time_frame>
    <description>Breast cancer recurrence rate in both arms after a median follow-up of 5, 10 and 15 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>axillary recurrence rate</measure>
    <time_frame>5, 10 and 15 years</time_frame>
    <description>The rate of axillary relapse in specific after a median follow-up of 5, 10 and 15 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>5, 10 and 15 years</time_frame>
    <description>The rate of overall deaths after a median follow-up of 5, 10 and 15 years</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Axillary clearance</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this arm will be treated by completion axillary clearance after a sentinel node biopsy showing 1-2 nodes with macrometastasis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No axillary clearance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will not undergo further axillary surgery after a sentinel node biopsy showing 1-2 nodes with macrometastasis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Omission of axillary clearance</intervention_name>
    <description>The intervention is the omission of completion axillary clearance after the detection of sentinel node macrometastasis</description>
    <arm_group_label>No axillary clearance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with invasive breast cancer (T1-T3)

          -  N0 on palpation

          -  Preoperative ultrasound performed

          -  Pathology report shows macrometastasis in 1-2 sentinel lymph nodes

          -  Patients undergo breast-conserving therapy or mastectomy

          -  The patient must have provided oral and written consent

          -  Age ≥ 18 years

        Exclusion Criteria:

          -  Metastases outside of the ipsilateral axilla

          -  Prior history of invasive breast cancer

          -  Pregnancy

          -  Bilateral breast cancer if one side meets exclusion criteria

          -  Medical contraindication for radiotherapy or systemic treatment

          -  Inability to absorb or understand the meaning of the study information; for example,
             through disability, inadequate language skills or dementia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jana de Boniface, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan Frisell, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Karolinska University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leif Bergkvist, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Central Hospital Västerås</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yvette Andersson, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Central Hospital Västerås</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lisa Ryden, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Malin Sund, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Umeå University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olofsson Roger, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johan Ahlgren, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Region Örebro County</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dan Lundstedt, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peer Christiansen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tove Tvedskov Filtenborg, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet Copenhagen, Dnmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michalis Kontos, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Athens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Birgitte Offersen, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thorsten Kühn, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Esslingen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Toralf Reimer, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universität Rostock</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jana de Boniface, PhD</last_name>
    <phone>+46858701000</phone>
    <phone_ext>1804</phone_ext>
    <email>jana.de-boniface@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leif Bergkvist, Professor</last_name>
    <phone>+4621173000</phone>
    <email>leif.bergkvist@ltv.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sygehus Sonderjylland</name>
      <address>
        <city>Aabenraa</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jürgen Handler</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ute Hoyer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peer Christiansen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tove Tvedskov Filtenborg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sydvestjysk Sygehus</name>
      <address>
        <city>Esbjerg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lena Carstensen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sygehus Lillebaelt</name>
      <address>
        <city>Lillebaelt</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Lautrup</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrine Soe</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Randers Regionshospitalet</name>
      <address>
        <city>Randers</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peer Christiansen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regionshospitalet Viborg</name>
      <address>
        <city>Viborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inge Scheel Andersen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Athens University Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michalis Kontos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gävle sjukhus</name>
      <address>
        <city>Gävle</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gyula Nagy</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Göteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger Olofsson, PhD</last_name>
      <email>roger.olofsson@surgery.gu.se</email>
    </contact>
    <investigator>
      <last_name>Roger Olofsson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hallands sjukhus</name>
      <address>
        <city>Halmstad</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann-Christin Källström</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsingborg lasarett</name>
      <address>
        <city>Helsingborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna-Karin Falck</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Länssjukhuset Ryhov</name>
      <address>
        <city>Jönköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecka Malterling</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kalmar sjukhus</name>
      <address>
        <city>Kalmar</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Sundqvist</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Blekinge sjukhuset</name>
      <address>
        <city>Karlskrona</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Sjövall</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karlstad sjukhus</name>
      <address>
        <city>Karlstad</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Ohlsson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Hospital Kristianstad</name>
      <address>
        <city>Kristianstad</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shabaz Majid</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Hedin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Malmö/Lund University Hospital</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Ryden, PhD</last_name>
      <email>lisa.ryden@skane.se</email>
    </contact>
    <investigator>
      <last_name>Lisa Ryden, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skaraborgs sjukhus</name>
      <address>
        <city>Skövde/Lidköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Per Nyman</last_name>
    </contact>
    <contact_backup>
      <last_name>Anja Lundberg</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helena Sackey, PhD</last_name>
      <phone>+46851770000</phone>
      <email>helena.ikonomidis-sackey@sll.se</email>
    </contact>
    <investigator>
      <last_name>Helena Sackey, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Gerenal Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fuat Celebioglu, PhD</last_name>
      <email>fuat.celebioglu@sodersjukhuset.se</email>
    </contact>
    <investigator>
      <last_name>Fuat Celebioglu, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Görans Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Norenstedt, PhD</last_name>
      <email>sophie.norenstedt@capiostgoran.se</email>
    </contact>
    <investigator>
      <last_name>Sophie Norenstedt, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sundsvall länssjukhus</name>
      <address>
        <city>Sundsvall</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotta Wadsten</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uddevalla sjukhus</name>
      <address>
        <city>Uddevalla</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carin Wångblad</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Umeå University Hospital</name>
      <address>
        <city>Umeå</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malin Sund</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Akademiska Sjukhuset</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fredrik Wärnberg, PhD</last_name>
      <email>fredrik.warnberg@akademiska.se</email>
    </contact>
    <investigator>
      <last_name>Fredrik Wärnberg, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Varbergs sjukhus</name>
      <address>
        <city>Varberg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Wallberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Västervik Hospital</name>
      <address>
        <city>Västervik</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Gustafsson, PhD</last_name>
      <email>peter.gustafsson2@ltkalmar.se</email>
    </contact>
    <investigator>
      <last_name>Peter Gustafsson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Västerås Central Hospital</name>
      <address>
        <city>Västerås</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvette Andersson, PhD</last_name>
      <phone>+4621173000</phone>
      <email>yvette.andersson@ltv.se</email>
    </contact>
    <investigator>
      <last_name>Yvette Andersson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Wedin</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Greece</country>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://senomac.se</url>
    <description>study homepage</description>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2014</study_first_submitted>
  <study_first_submitted_qc>September 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2014</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Jana de Boniface</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>sentinel node biopsy, lymph node metastasis, survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://senomac.se/Home/study%20protocol.html</doc_url>
      <doc_comment>Study protocol and patient information (English)</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

